Skip to main content

Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region

Written by Customer Service on . Posted in Public Companies.

SUNNYVALE, Calif., June 22, 2021 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, recently announced the opening of a new office in Plymouth, Minnesota, to accommodate growing demand for TransCarotid Artery Revascularization (TCAR) and to access the local talent pool of aspiring and experienced med tech professionals.

“We continue to invest in our long-term growth and are excited to expand our operations to include a facility in Plymouth. Medical Alley has a rich history of technological innovation and serves as a great complement to our continued and growing presence in Silicon Valley,” said Erica Rogers, President and Chief Executive Officer of Silk Road Medical.

The new location extends Silk Road Medical’s footprint and provides further operational capability to meet growing interest in the company’s less invasive stroke prevention technology. In addition to increased R&D infrastructure, Silk Road Medical anticipates significant job growth as they expand their Minnesota presence.

This announcement comes on the heels of Silk Road Medical being certified as a Great Place to Work; the only recognition based entirely on what employees report about their workplace experience. 95% of employees said Silk Road Medical is a great place to work, compared to 59% of employees at a typical U.S.-based company.

“The addition of Silk Road Medical to the Greater MSP region will deepen our strength in cutting-edge medical technologies and bring new jobs in research and manufacturing,” said Peter Frosch, President and CEO of GREATER MSP. “We look forward to working with Silk Road’s leadership team to support their success and growth in the years ahead.”

“We are thrilled to welcome Silk Road Medical to Minnesota’s economy and congratulate them on their growth,” said Minnesota Department of Employment and Economic Development Commissioner Steve Grove. “This expansion outside of California to Minnesota will be met with opportunities to continue growth with our innovative, talented workforce and strong business climate.” 

“We are excited to welcome Silk Road Medical and their groundbreaking technology to Plymouth,” said Danette Parr, Economic Development Manager for the City of Plymouth. “We wish them great success as they continue to grow.”

About TCAR with the ENROUTE Transcarotid Neuroprotection and Stent System
TCAR (TransCarotid Artery Revascularization) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the ENROUTE Transcarotid Neuroprotection System (NPS) during the TCAR procedure. The ENROUTE Transcarotid NPS is a first in class device used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

About GREATER MSP 
GREATER MSP is the economic development partnership for the 15-county Minneapolis Saint Paul region. Over 300 leading businesses, universities, cities, counties, philanthropies, and others are working together to accelerate the competitiveness of the regional economy and drive inclusive economic growth through job creation, capital investment and the execution of strategic initiatives.  For more information go to greatermsp.org.

Investors:
Lynn Lewis or Caroline Paul
Gilmartin Group
investors@silkroadmed.com

Media:
Michael Fanucchi
Silk Road Medical
mfanucchi@silkroadmed.com

Maggie Habashy
GREATER MSP
Maggie.habashy@greatermsp.org

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.